In AD, differences in endocytic trafficking and processing of amyloid precursor protein (APP) to its cytotoxic product Aβ can explain the involvement of endocytic traffic in AD pathogenesis (Toh and Gleeson, 2016). Here, APP is linked to Alzheimer disease.